摘要
目的：：对雾化吸入布地奈德混悬液联合沙丁胺醇液治疗 COPD急性加重期疗效进行研究.方法：将2012年6月~2013年9月，我院接诊的56例 AECOPD患者作为研究对象.随机将患者分为对照组与观察组，对照组28例患者接受常规治疗，观察组28例患者在常规治疗的基础上，使用雾化吸入布地奈德混悬液联合沙丁胺醇液辅助治疗.结果：治疗结束后，两组患者肺功能与呼吸困难较治疗前获得明显改善.相较于对照组，观察组患者治疗效果明显更佳，两组对比差异显著(P＞0．05)，具有统计学意义.治疗期间，观察组患者未出现任何不适感或严重并发症.结论：使用雾化吸入布地奈德混悬液联合沙丁胺醇液治疗急性加重期 COPD患者，能够取得理想的治疗效果，安全性高，适合于临床推广应用.
Abstract
Objective:To study the clinical treatment of atomization inhalation of budesonide suspension combined ventolin liquid to acute Aggravating Period of COPD.Methods:Make the 56 patients with AECOPD in our hospital departments between June 2012 and September 2013 as the research object.Patients randomly divided into control group and observation group and control group in 28 patients were treated with conventional,28 patients in the observation group,on the basis of conventional treatment,using atomizing inhalation budesonide suspension liquid combined ventolin liquid adjuvant theraG py.Result:After the treatment,two groups of patients with pulmonary functions and dyspnea than before treatment was obviously improved.Compared with the control group and observation group of paG tients with better treatment ef ect is obvious,significant dif erence comparing the two groups(P>0.05),with statistical significance.During the treatment,observation group of patients without any discomG fort or severe complications.Conclusion:Treat the patients with COPD in acute aggravating period using atomizing inhalation budesonide suspension liquid combined ventolin liquid can obtain ideal treatment ef ect,high safety,suitable for clinical application.
NETL
NSTL
万方数据